BioCentury | Dec 4, 2018
Distillery Therapeutics

Neurology

...CONTACT: Erich E. Wanker, Max Delbrück Center for Molecular Medicine Berlin-Buch, Berlin, Germany email: ewanker@mdc-berlin.de Claire Quang Max Delbrueck Center for Molecular Medicine Berlin-Buch Amyloid...
BioCentury | Oct 31, 2017
Distillery Techniques

Biomarkers

...CONTACT: Young-Ae Lee, Max Delbrück Center for Molecular Medicine Berlin-Buch, Berlin, Germany email: yolee@mdc-berlin.de Elizabeth S. Eaton Max Delbrueck Center for Molecular Medicine Berlin-Buch University...
BioCentury | Oct 24, 2017
Preclinical News

GWAS identify new risk loci in allergies and breast cancer

...allergies and breast cancer. In a paper published in Nature Communications , researchers at the Max Delbrueck Center for Molecular Medicine Berlin-Buch...
...by Cancer Council Victoria identified 10 new loci variants for estrogen receptor-negative breast cancer. Elizabeth S. Eaton Max Delbrueck Center for Molecular Medicine Berlin-Buch University...
BioCentury | Jul 13, 2017
Translation in Brief

Mind over matter

...weight and energy homeostasis by neuronal cell adhesion molecule 1." Nature Neuroscience (2017) Winnie Pong, Staff Writer Max Delbrueck Center for Molecular Medicine Berlin-Buch Cell...
BioCentury | Jul 10, 2017
Distillery Therapeutics

Endocrine / Metabolic

...2017 doi:10.1038/nn.4590 CONTACT: Matthew Poy, Max Delbrück Center for Molecular Medicine, Berlin, Germany email: matthew.poy@mdc-berlin.de Winnie Pong Max Delbrueck Center for Molecular Medicine Berlin-Buch Cell...
BioCentury | Feb 10, 2017
Company News

Max Delbrueck Center for Molecular Medicine Berlin-Buch, Wilex deal

...Center for Molecular Medicine Berlin-Buch , Berlin, Germany Wilex AG (Xetra:WL6), Munich, Germany Business: Cancer Alicia Parker HDP-101 Max Delbrueck Center for Molecular Medicine Berlin-Buch Wilex...
BioCentury | Jan 11, 2017
Distillery Therapeutics

Neurology

...email: k.poole@unsw.edu.au CONTACT: Gary R. Lewin, same affiliation as above email: glewin@mdc-berlin.de Hongjiang Li Lead Discovery Center GmbH Max Delbrueck Center for Molecular Medicine Berlin-Buch Piezo-type...
BioCentury | Sep 26, 2016
Company News

Max Delbrueck Center for Molecular Medicine Berlin-Buch, Wilex deal

...myeloma (MM). Wilex declined to disclose financial terms, and MDC did not respond to inquiries. Max Delbrueck Center for Molecular Medicine Berlin-Buch...
BioCentury | Aug 24, 2015
Company News

Formula Pharmaceuticals, Max Delbrueck Center for Molecular Medicine Berlin-Buch deal

...autoimmune disease. The partners declined to provide further details. Formula Pharmaceuticals Inc. , Berwyn, Pa. Max Delbrueck Center for Molecular Medicine Berlin-Buch...
BioCentury | Oct 23, 2014
Distillery Therapeutics

Indication: Cancer

...K. et al. Cancer Discov.; published online Sept. 24, 2014; doi:10.1158/2159-8290.CD-14-0096 Contact: Uta E. Höpken, Max Delbrueck Center for Molecular Medicine...
Items per page:
1 - 10 of 19
BioCentury | Dec 4, 2018
Distillery Therapeutics

Neurology

...CONTACT: Erich E. Wanker, Max Delbrück Center for Molecular Medicine Berlin-Buch, Berlin, Germany email: ewanker@mdc-berlin.de Claire Quang Max Delbrueck Center for Molecular Medicine Berlin-Buch Amyloid...
BioCentury | Oct 31, 2017
Distillery Techniques

Biomarkers

...CONTACT: Young-Ae Lee, Max Delbrück Center for Molecular Medicine Berlin-Buch, Berlin, Germany email: yolee@mdc-berlin.de Elizabeth S. Eaton Max Delbrueck Center for Molecular Medicine Berlin-Buch University...
BioCentury | Oct 24, 2017
Preclinical News

GWAS identify new risk loci in allergies and breast cancer

...allergies and breast cancer. In a paper published in Nature Communications , researchers at the Max Delbrueck Center for Molecular Medicine Berlin-Buch...
...by Cancer Council Victoria identified 10 new loci variants for estrogen receptor-negative breast cancer. Elizabeth S. Eaton Max Delbrueck Center for Molecular Medicine Berlin-Buch University...
BioCentury | Jul 13, 2017
Translation in Brief

Mind over matter

...weight and energy homeostasis by neuronal cell adhesion molecule 1." Nature Neuroscience (2017) Winnie Pong, Staff Writer Max Delbrueck Center for Molecular Medicine Berlin-Buch Cell...
BioCentury | Jul 10, 2017
Distillery Therapeutics

Endocrine / Metabolic

...2017 doi:10.1038/nn.4590 CONTACT: Matthew Poy, Max Delbrück Center for Molecular Medicine, Berlin, Germany email: matthew.poy@mdc-berlin.de Winnie Pong Max Delbrueck Center for Molecular Medicine Berlin-Buch Cell...
BioCentury | Feb 10, 2017
Company News

Max Delbrueck Center for Molecular Medicine Berlin-Buch, Wilex deal

...Center for Molecular Medicine Berlin-Buch , Berlin, Germany Wilex AG (Xetra:WL6), Munich, Germany Business: Cancer Alicia Parker HDP-101 Max Delbrueck Center for Molecular Medicine Berlin-Buch Wilex...
BioCentury | Jan 11, 2017
Distillery Therapeutics

Neurology

...email: k.poole@unsw.edu.au CONTACT: Gary R. Lewin, same affiliation as above email: glewin@mdc-berlin.de Hongjiang Li Lead Discovery Center GmbH Max Delbrueck Center for Molecular Medicine Berlin-Buch Piezo-type...
BioCentury | Sep 26, 2016
Company News

Max Delbrueck Center for Molecular Medicine Berlin-Buch, Wilex deal

...myeloma (MM). Wilex declined to disclose financial terms, and MDC did not respond to inquiries. Max Delbrueck Center for Molecular Medicine Berlin-Buch...
BioCentury | Aug 24, 2015
Company News

Formula Pharmaceuticals, Max Delbrueck Center for Molecular Medicine Berlin-Buch deal

...autoimmune disease. The partners declined to provide further details. Formula Pharmaceuticals Inc. , Berwyn, Pa. Max Delbrueck Center for Molecular Medicine Berlin-Buch...
BioCentury | Oct 23, 2014
Distillery Therapeutics

Indication: Cancer

...K. et al. Cancer Discov.; published online Sept. 24, 2014; doi:10.1158/2159-8290.CD-14-0096 Contact: Uta E. Höpken, Max Delbrueck Center for Molecular Medicine...
Items per page:
1 - 10 of 19